Abstract
Breast cancer is a leading cause of mortality in women. In Malaysia, it is the most common cancer to affect women. The most common form of breast cancer is infiltrating ductal carcinoma (IDC). A proteomic approach was undertaken to identify protein profile changes between cancerous and normal breast tissues from 18 patients. Two protein extracts; aqueous soluble and membrane associated protein extracts were studied. Thirty four differentially expressed proteins were identified. The intensities of the proteins were used as variables in PCA and reduced data of six principal components (PC) were subjected to LDA in order to evaluate the potential of these proteins as collective biomarkers for breast cancer. The protein intensities of SEC13-like 1 (isoform b) and calreticulin contributed the most to the first PC while the protein intensities of fibrinogen beta chain precursor and ATP synthase D chain contributed the most to the second PC. Transthyretin precursor and apolipoprotein A-1 precursor contributed the most to the third PC. The results of LDA indicated good classification of samples into normal and cancerous types when the first 6 PCs were used as the variables. The percentage of correct classification was 91.7% for the originally grouped tissue samples and 88.9% for cross-validated samples.
Highlights
Breast cancer is one of the major causes of death worldwide
The proteins’ grand average of hydropathy (GRAVY) score indicates the hydrophilicity of the proteins, whereby the more negative the score, the higher is the hydrophilic
The results indicated good classification of samples into normal and cancerous types when the first 6 principal components (PC) were used as the variables
Summary
Breast cancer is one of the major causes of death worldwide. It is responsible for 519 000 deaths around the world each year [1]. Breast cancer is the most common cancer affecting women, comprising 16% of all female cancer cases [2]. Invasive ductal carcinoma is the most common form of invasive breast cancer, accounting for 85% of all breast cancer cases [4]. Proteomics approach has been used to identify protein biomarkers in breast cancer [6,7,8,9,10,11] and other types of cancers [12,13,14,15].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.